NClip

Alpha-2 Agonists

2 min read

Alpha-2 Agonists

Key Points

  • Clonidine is the prototype alpha-2 agonist in this source context.
  • Alpha-2 agonists reduce central sympathetic outflow and lower peripheral vascular resistance.
  • Clinical uses include hypertension and ADHD.
  • Monitor for hypotension, bradycardia, and sedation.
  • Do not stop clonidine abruptly because rebound hypertension can occur.
  • Teach consistent daily dosing, orthostatic precautions, and avoidance of alcohol co-use.

Mechanism of Action

Alpha-2 agonists stimulate central alpha-2 receptors, reducing sympathetic outflow from the CNS. This lowers peripheral and renal vascular resistance, contributing to blood-pressure reduction.

Indications

  • Hypertension
  • Attention-deficit/hyperactivity disorder (ADHD)

Nursing Considerations

  • Monitor blood pressure and pulse before and during therapy.
  • Watch for hypotension, bradycardia, sedation, and excessive drowsiness.
  • Screen for orthostatic symptoms and fall risk, especially at initiation or dose changes.
  • Reinforce strict adherence and tapering plans; abrupt discontinuation can trigger rebound hypertension.

Adverse Effects

  • Hypotension
  • Bradycardia
  • Sedation/drowsiness
  • Rebound hypertension after abrupt discontinuation
  • Orthostatic blood pressure changes

Health Teaching

  • Take doses on a consistent daily schedule.
  • Change positions slowly to reduce orthostatic symptoms.
  • Avoid alcohol while taking clonidine because CNS-depressant effects can worsen sedation and safety risk.
  • Use caution with exercise and hot environments because blood-pressure shifts may be more pronounced.
  • Report persistent depressed mood or functional decline for therapy reassessment.

Alpha-2 Antagonist Context

In this source, alpha-2 antagonists are described as having limited routine clinical application and primarily research use.

Clinical Judgment Application

Clinical Scenario

A patient on clonidine misses multiple doses and presents with headache, elevated blood pressure, and dizziness.

  • Recognize Cues: Missed alpha-2 agonist doses with possible rebound-hypertension pattern.
  • Analyze Cues: Abrupt interruption of clonidine can produce sympathetic rebound and hemodynamic instability.
  • Prioritize Hypotheses: Priority is blood-pressure stabilization and prevention of acute complications.
  • Generate Solutions: Reconcile adherence history, reassess vitals frequently, and notify provider for safe re-initiation/taper planning.
  • Take Action: Implement ordered monitoring and reinforce no-abrupt-stop teaching.
  • Evaluate Outcomes: Blood pressure stabilizes and patient demonstrates correct dosing/stop-plan understanding.

Graph View

Backlinks